02407 GAUSH MEDITECH
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 2.25X | Oper Margin | 13.4% |
|---|---|---|---|
| LT Debt/Equity | 23.0% | Net Margin | 6.5% |
| Total Debt/Equity | 35.1% | Return on Equity | 5.9% |
| Price/Book | 0.70X | Return on Assets | 3.6% |
| (HKD 7.930) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 98.26 | 191.26 | -391.99 | -232.94 | 117.93 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | -48.6 | +148.8 | -68.3 | -297.5 | +384.8 |
| Earnings Per Share (HKD) | 0.665 | 1.293 | -4.043 | -2.431 | 1.119 |
| Earnings Per Share Growth (%) | -48.6 | +132.0 | -66.4 | -317.1 | +394.4 |
| Dividend Per Share (HKD) | 0.300 | 1.100 | No dividend | No dividend | No dividend |
| P/E* (X) | 11.93 | 6.14 | N/A | N/A | 7.08 |
| Yield (%) | 3.78 | 13.87 | N/A | N/A | N/A |
| Dividend Share (%) | 45.13 | 85.11 | N/A | N/A | N/A |
| Book NAV (HKD) | 11.327 | 12.517 | 11.138 | N/A | N/A |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | N/A | N/A |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 1,428 | 1,406 | +1.6 | 1,254 |
| Operating Result | 155.287 | 247.589 | -37.3 | -275.094 |
| Profit Before Taxation | 155.287 | 247.735 | -37.3 | -275.094 |
| Taxation | 66.764 | 74.821 | -10.8 | 77.618 |
| Profit /( Loss) After Taxation | 88.523 | 172.914 | -48.8 | -352.712 |
| Minority Interests | -3.871 | -0.609 | +535.6 | -3.093 |
| Net Profit | 92.394 | 173.523 | -46.8 | -349.619 |
| Earnings Per Share () | 0.6647 | 1.2925 | -48.6 | -4.0433 |
| Dividend Per Share () | 0.3000 | 1.1000 | -72.7 | 0.0000 |
| Announcement Date | 2025-03-26 | 2024-03-25 | NA | 2023-03-31 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
